⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Official Title: A Phase 2, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Study ID: NCT04052997

Study Description

Brief Summary: The purpose of this study is to evaluate the clinical efficacy and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory Hodgkin Lymphoma (HL).

Detailed Description: This is a phase 2, multi-center, open-label, single-arm study of efficacy and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory Hodgkin lymphoma. This study will enroll approximately 100 participants. Camidanlumab Tesirine (ADCT-301) is an antibody drug conjugate (ADC), composed of the human monoclonal antibody, HuMax®-TAC, which is directed against human CD25. The antibody is conjugated through a protease cleavable linker to SG3199, a pyrrolobenzodiazepine (PBD) dimer cytotoxin. For each participant the study will include a screening period (of up to 28 days), a treatment period (cycles of 3 weeks), and a follow-up period (approximately every 12-week visits) for up to 3 years after treatment discontinuation. Participants may continue treatment for up to 1 year or until disease progression, unacceptable toxicity, or other discontinuation criteria, whichever occurs first. Additionally, patients benefiting clinically at 1 year may continue treatment after a case by case review with the Sponsor.

Eligibility

Minimum Age: 16 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Mayo Clinic - Arizona, Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center, Duarte, California, United States

UCSF Health - Hematology and Blood and Marrow Transplant Clinic, San Francisco, California, United States

Stanford University Medical Center, Stanford, California, United States

Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States

Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

Northside Hospital - Atlanta, Atlanta, Georgia, United States

The University of Chicago Medicine, Chicago, Illinois, United States

Norton Cancer Institute - Saint Matthews, Louisville, Kentucky, United States

University of Minnesota, Minneapolis, Minnesota, United States

Mayo Clinic, Rochester, Minnesota, United States

Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, United States

Hackensack University Medical Center, Hackensack, New Jersey, United States

Memorial Sloan-Kettering Cancer Center - New York, New York, New York, United States

Stony Brook University Cancer Center, Stony Brook, New York, United States

University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States

Cleveland Clinic - Taussig Cancer Center, Cleveland, Ohio, United States

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Hollings Cancer Center, Charleston, South Carolina, United States

University of Texas Southwestern Medical Center, Dallas, Texas, United States

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Virginia Cancer Specialists, Fairfax, Virginia, United States

Froedtert Hospital, Milwaukee, Wisconsin, United States

Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan, Brugge, , Belgium

Cliniques Universitaires Saint-Luc, Brussels, , Belgium

Grand Hôpital de Charleroi - Notre Dame, Charleroi, , Belgium

Hôpital de Jolimont, La Louvière, , Belgium

Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne, Yvoir, , Belgium

British Columbia Cancer Agency, Vancouver, British Columbia, Canada

The Ottawa Hospital - General Campus, Ottawa, , Canada

Princess Margaret Cancer Centre, Toronto, , Canada

Fakultní Nemocnice Brno, Brno, , Czechia

Vseobecna fakultni nemocnice v Praze, Prague, , Czechia

Fakultní Nemocnice Královské Vinohrady, Praha 10, , Czechia

Hôpitaux Universitaires Henri Mondor, Créteil, , France

Hôpital François Mitterrand, Dijon, , France

Clinique Victor Hugo Le Mans, Le Mans, , France

Hôpital Saint-Eloi, Montpellier, , France

Hôpital Haut-Lévêque, Pessac, , France

Centre Hospitalier Lyon-Sud, Pierre-Bénite, , France

Hôpital Pontchaillou, Rennes, , France

Centre de Lutte Contre le Cancer - Centre Henri-Becquerel, Rouen, , France

Universitätsklinikum Halle, Halle, , Germany

Debreceni Egyetem Klinikai Központ, Debrecen, , Hungary

Pécsi Tudományegyetem, Pécs, , Hungary

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo - Alessandria, Alessandria, , Italy

Azienda Ospedaliero-Universitaria di Bologna Policlinico Sant Orsola-Malpighi, Bologna, , Italy

Istituto Clinico Humanitas, Milan, , Italy

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, , Italy

Istituto Oncologico Veneto - IRCCS, Padova, , Italy

Szpital Wojewódzki w Opolu, Opole, , Poland

Dolnośląskie Centrum Transplantacji Komórkowych z Krajowym Bankiem Dawców Szpiku, Wrocław, , Poland

Hospital de la Santa Creu i Sant Pau, Barcelona, , Spain

Hospital Universitari Vall d'Hebrón, Barcelona, , Spain

Hospital Clínic de Barcelona, Barcelona, , Spain

Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), Barcelona, , Spain

Hospital General Universitario Gregorio Marañón, Madrid, , Spain

Hospital Universitario Fundación Jiménez Díaz, Madrid, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

Hospital Universitario La Paz, Madrid, , Spain

Hospital Universitario HM Sanchinarro, Madrid, , Spain

Hospital Universitario Ramón y Cajal, Madrid, , Spain

Hospital Universitario Quirónsalud Madrid, Pozuelo De Alarcón, , Spain

Complejo Asistencial Universitario de Salamanca - Hospital Clínico, Salamanca, , Spain

Hospital Universitari i Politècnic La Fe, Valencia, , Spain

Hospital Clínico Universitario de Valencia, València, , Spain

NHS Greater Glasgow and Clyde, Glasgow, , United Kingdom

University College London Hospitals NHS Foundation Trust, London, , United Kingdom

The Royal Marsden NHS Foundation Trust, London, , United Kingdom

The Christie NHS Foundation Trust, Manchester, , United Kingdom

Oxford University Hospitals NHS Foundation Trust, Oxford, , United Kingdom

University Hospitals Plymouth NHS Trust, Plymouth, , United Kingdom

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: